b cell in English
Use "b cell" in a sentence
1. CD4+ Clonality correlates with CD8+ Clonality and B-cell phenotypes
2. Together, Atmin deficiency leads to genomic instability and B cell lymphomas.
3. Cutaneous B-cell lymphoma Cutaneous B-cell lymphoma is a rare type of skin cancer that may form as a nodule that appears the same color as your skin
4. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling.
5. Perisinusoidal amyloidosis can be the first sign of an underlying B-cell neoplasia.
6. Binding molecule having influenza a virus-neutralizing activity produced from human b cell
7. Clonality analysis of B-cell populations can aid in the diagnosis of lymphoproliferative disorders
8. 9 In contrast, mice conditionally deleted of Atmin using Mx1-Cre developed B-cell lymphopenia
9. The B cell then displays these antigenic peptides on its surface MHC class II molecules.
10. X-linked Agammaglobulinemia (XLA), a more uncommon humoral immune defect than CVID, is due to an abnormality of an X chromosome–encoded B-cell cytoplasmic tyrosine kinase necessary for B-cell maturation (Conley et al., 1994)
11. 13 Objective : To explore expression of EBV - LMPI and ZEBRA in B cell in SLE patients.
12. The pathological assessment confirmed the diagnosis of a diffuse B cell lymphoma with an activated B cells’ phenotype.
13. B-cell Prolymphocytic Leukemia (T-PLL) is a mature post-thymic T-cell malignancy with aggressive clinical course.
14. 133 In vitro studies have demonstrated that Astragalus promotes B-cell proliferation and antibody production and enhances CTL activity
15. Diseases associated with Bad include B-Cell Lymphoma and Transient Cerebral Ischemia.Among its related pathways are MAPK Signaling: Oxidative Stress Pathway and Downstream signaling events of B Cell Receptor (BCR).Gene Ontology (GO) annotations related to this gene include protein heterodimerization activity and lipid …
16. 25 Conclusions This case of LYG is a rare lymphomatoid granulomatosis-type large B cell lymphoma, with EBV related.
17. Large Cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas
18. The strength of the immune system's response was gauged by B cell activity in both the stomach and small intestine.
19. The nodule can also appear pink or purple. Cutaneous B-cell lymphoma is a rare type of cancer that begins in …
20. Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases.
21. Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases
22. Precision treatment of distinct molecular subtypes of diffuse large B-cell lymphoma: Ascribing treatment based on the molecular phenotype Clin Cancer Res
23. To Characterize vaccine-induced B cell response, the scientists isolated plasmablasts from the blood samples of the vaccinated individuals and subsequently screened all …
24. An Antigen-specific B cell antibody specifically recognizes a TI-2 Antigen, but without T cell help, a memory response is not seen.
25. If your doctor tells you that you have B-Cell lymphoma, it means you have a cancer that forms in white blood Cells called lymphocytes
26. Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
27. Antibody When bacteria enter a flesh wound, a B cell releases antibodies, which attach to the bacteria and direct them toward a macrophage for destruction
28. Nodular Sclerosing Hodgkin Disease (HD) and Follicular Small Cleaved Cell (NHL) Composite Lymphomas NHL NHL Age/Sex/Source Site Diagnosis Phenotype 66/F/Jaffe et al(1) Lymph node Follicular B cell (unspecified small Cleaved site) type 78/M/present study Lymph node Follicular small B cell (inguinal type Cleaved region type HD HD Age/Sex/Source
29. Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases
30. 8 We have previously shown that Atmin-deleted B cells (induced by CD19-Cre) have impaired class switch recombination and increased genomic instability, leading to B-cell lymphomas
31. Agammaglobulinemia is a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development
32. The production of Antibodies is a major function of the immune system and is carried out by a type of white blood cell called a B cell (B lymphocyte)
33. The Bronchus-associated lymphoid tissue (BALT) and the nasal-associated lymphoid tissue (NALT) constitute organized lymphoid aggregates that are capable of T- and B-cell responses to inhaled antigens
34. Ig Clonality was also identified, especially in AILT, which reflects the known pathophysiologic occurrence of B-cell clones in AILT; Ig Clonality in the other entities was generally rather limited [34]
35. A 73-year-old woman with B-cell lymphatic leukemia with a secondary antibody deficiency syndrome and anemia suffered for one year with perianal ulcerations caused by acyclovir-resistant herpes simplex infection Type II.
36. About 76% of T-cell neoplasms are reported to express CD5, and it is also found in chronic lymphocytic leukemia and mantle cell lymphoma (both being B cell malignancies), that do not express CD3.
37. Good prognosis patients (the low and low–intermediate risk groups or age-adjusted (aa)IPI=0, 1) with diffuse large B-cell lymphomas are best treated with six cycles of CHOP-21 plus rituximab.
38. By giving a safe form of the antigen Artificially, the body will produce its own antibodies and, more importantly, develop circulating, long-lived B-memory cells with high affinity B-cell receptors on their surface.
39. The ratio of antigen label to IgG label can be calculated for each labeled B cell. The higher the ratio, the higher the relative affinity of the antibodies on the B cells for the antigen.
40. Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, announced on January 29, 2020 that the U.S
41. Mouse T cells transduced with an all-murine CD3ζ/CD28-based CAR that is equivalent to the one being used in our clinical trials, eradicate B-ALL in mice and mediate long-term B cell Aplasias
42. Leadership team: Cabaletta Bio has brought together leading scientists and experts in cell therapy and autoimmune disease to develop CAAR T cell therapies that offer a potential one-time cure of B cell-mediated autoimmune diseases.
43. Detection of the same dominant B-cell clone in BAL fluid and lymphomatous pulmonary biopsy has been reported by Southern blot 15 , 16 , 26 and, in our more recent work, by PCR, 17 suggesting that alveolar lymphocytes Clonality
44. The best results for young patients with diffuse large B-cell lymphomas (DLBCL) and a good prognosis (low and low-intermediate risk group or age-adjusted IPI/aaIPI = 0.1) are obtained with 6 cycles of CHOP-21 plus rituximab.
45. ‘Other Aberrant gametophyte phenotypes were observed among the group of mutants that could form antheridia.’ ‘Flow cytometric immunophenotyping did not reveal an Aberrant T cell or monoclonal B-cell population.’ ‘When a damaged cell is unable to repair itself, an Aberrant …
46. ‘Other Aberrant gametophyte phenotypes were observed among the group of mutants that could form antheridia.’ ‘Flow cytometric immunophenotyping did not reveal an Aberrant T cell or monoclonal B-cell population.’ ‘When a damaged cell is unable to repair itself, an Aberrant …
47. Agammaglobulinemia is a form of primary immunodeficiency demarcated by defects in B-cell function due to gene mutations encoding the Bruton tyrosine kinase protein on chromosome X, which is why the term X-linked Agammaglobulinemia is used in the literature
48. In the lymph nodes, a mature B cell, activated by helper T cells and related antigen, “proliferates and differentiates to form plasma cells that secrete identical antibodies with a single specificity at a rate of about 10,000 molecules per cell per second.” —Immunology.
49. Moving from left to right, depicting the healthy Adventitia, the phenotypic switch from fibroblast to myofibroblast, vasa vasorum neovascularization, lipid oxidation, generation of foam cells, B cell maturation and contribution to the local humoral immune response, and transmigration of monocytes into the
50. Negative regulation of B cell responses and self-tolerance to RNA-related lupus self-antigen Nadler, "Human T-cell clonal Anergy is induced by antigen presentation in the absence of B7 costimulation," Proceedings of the National Acadamy of Sciences of the